GGrantIndex
← Search

HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS

$2,740,852N01FY2010AINIH

Profectus Biosciences, Inc., Baltimore MD

Investigators

Abstract

Provide a research and administrative team that includes all expertise needed for the development, optimization, pre-clinical and clinical testing, and production of an HIV/AIDS vaccine based vesicular stomatitis virus (rVSV) as delivery tool of HIV vaccine immunogens

View original record on NIH RePORTER →